Predictive value of thrombus characteristics on recanalization rate and clinical outcome in acute posterior stroke patients receiving endovascular therapy by Shu, Liang
		
From the Klinik für Radiologie und Neuroradiologie 
Director: Prof. Dr. med. Olav Jansen 
 
at the University Medical Center Schleswig-Holstein, Campus Kiel 
at Kiel University 
 
PREDICTIVE VALUE OF THROMBUS 
CHARACTERISTICS ON RECANALIZATION 
RATE AND CLINICAL OUTCOME IN ACUTE 
POSTERIOR STROKE PATIENTS RECEIVING 
ENDOVASCULAR THERAPY 
 
Dissertation 
to acquire the doctoral degree in medicine 
at the Faculty of Medicine 
at Kiel University 
presented by 
LIANG SHU 
from Shanghai 
KIEL, 2018 
			
1st Reviewer: Prof. Dr. Olav Jansen, Klinik für Radiologie und 
Neuroradiologie 
2nd Reviewer: Prof. Dr. Ralf Baron, Klinik für Neurologie 
3. Date of oral examination: 18, 03, 2019 
Approved for printing, Kiel, dated 
Signed: 
			
CONTENTS 
 
ABBREVIATIONS  III 
   
GENERAL INTRODUCTION  -1- 
   
PART I. PREDICTIVE VALUE OF THROMBUS 
CHARACTERISTICS ON RECANALIZATION RATE AND 
CLINICAL OUTCOME IN ACUTE POSTERIOR STROKE 
PATIENTS RECEIVING ENDOVASCULAR THERAPY. 
 -3- 
   
PART II. THROMBUS DENSITY MEASUREMENTS ON 
NON-ENHANCED CRANIAL COMPUTED TOMOGRAPHY: 
COMPARISON OF THREE DIFFERENT METHODS. 
 -35- 
   
GERNAL DISCUSSION AND CONCLUSION  -55- 
   
BIBLIOGRAPHY  -58- 
   
ACKNOWLEDGMENT  -64- 
   
ACADEMIC CURRICULUM VITAE  -65- 
   
PUBLICATIONS  -68- 
 
			
Abbreviations 
AICA Anterior Inferior Cerebellar Artery 
BA Basilar Artery 
BAO Basilar Artery Occlusion 
CECT Contrast-Enhanced Computed Tomography 
CSF 
CT 
Cerebro-Spinal Fluid 
Computed Tomography 
CTA Computed Tomography Angiography 
CTP Computed Tomography Perfusion 
DSA Digital Subtraction Angiography 
ECASS European Cooperative Acute Stroke Study 
EVT Endovascular Therapy 
HAS Hyperdense Artery Sign 
HBAS 
HMCAS 
HU 
Hyperdense Basilar Artery Sign 
Hyperdense Middle Cerebral Sign 
Hounsfield Unit 
IAT Intra-Arterial Thrombolysis 
IQR Inter-Quartile Range 
IVT Intra-Vascular Thrombolysis 
MCAO Middle Cerebral Artery Occlusion 
MIP 
MRA 
MRI 
Maximum Intensity Projection 
Magnetic Resonance Angiography 
Magnetic Resonance Imaging 
mRS modified Rankin Scale 
NECCT Non-Enhanced Cranial Computed Tomography 
			
NIHSS National Institutes of Health Stroke Scale 
OTT Symptom Onset To Treatment 
PCA Posterior Cerebral Artery 
ROI Region of Interest 
rtPA recombinant tissue Plasminogen Activator 
sICH symptomatic Intra-Cranial Hemorrhage 
SVS Susceptibility Vessel Sign 
SWI Susceptibility Weighted Imaging 
SUCA Superior Cerebellar Artery 
TICI Thrombolysis In Cerebral Infarction 
TIMI Thrombolysis In Myocardial Infarction 
VA Vertebral Artery 
WBC White Blood Cell 
 
 
 
 
 
 
 
 
 
General Introduction                                                                        1 
		
General Introduction 
 
Acute occlusion of the basilar artery (BAO) is a devastating disease, resulting in really high fatality 
and morbidity if untreated. Historically, Endovascular therapy (EVT) has been the treatment of 
choice1. However, in contrast to the anterior circulation, the optimum treatment strategy for BAO has 
not been validated in randomized controlled trials since very few patients with BAO have been 
included in intravenous thrombolysis (IVT) trials. Most of our knowledge on the efficacy and safety 
on IVT in BAO stems from very few centers routinely performing IVT in these patients. For example, 
it was recently demonstrated that recanalization rate of occluded basilar artery receiving IVT (62.1%) 
depends on thrombus length2. 
  
More recently, five randomized controlled trials demonstrated the safety and effectiveness of EVT in 
patients with anterior circulation stroke3-7. BAO patients again had been almost completely excluded. 
The ENDOSTROKE registry8 claimed similar positive results in BAO patients treated with EVT. The 
recanalization rate in this study was up to 79% (117 /148) in patients with acute BAO whereas 34% 
(50/148) had favorable clinical outcome. In contrast, the BASICS registry9 could not prove the 
superiority of EVT. Recent smaller scale studie10 demonstrated high recanalization rates in patients 
with large vessel occlusion. However, only sixteen BAO patients were included in the cohort and in 
addition, six of them (12% of total) underwent thrombectomy alone due to IVT contraindications. 
Whether EVT is the prime treatment strategy for BAO is still uncertain. 
 
In the past decades, neuroimaging factors have taken on an important role in determining efficacy of 
different strategies of treatment and predicting clinical and radiological outcome in stroke patients. 
Since most of the studies have been performed in patients with anterior circulation stroke data on 
BAO patients is scarce. The aim of this study was to evaluate the prognostic value of thrombus 
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characteristics in patients with BAO. 
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Part I Impact of Thrombus Characteristics on Recanalization Rate and 
Clinical Outcome in Acute Posterior Stroke Patients Receiving 
Endovascular Therapy. 
 
Introduction 
Numerous prognostic factors, such as thrombus length measured on non-enhanced cranial computed 
tomography (NECCT) images11, 12, clot burden score calculated on magnetic resonance imaging (MRI) 
images13, and clot length assessed by using susceptibility weighted imaging (SWI), have been 
proposed to determine the efficacy of recanalization therapy and clinical outcome in patients with 
large vessel occlusion. However, the results are somewhat controversial. A key finding reported by 
Riedel was that there is little chance to reopen the occluded vessel in patients with acute middle 
cerebral occlusion after IVT if the thrombus length exceeded 8 mm12. Using computed tomography 
angiography (CTA), Rohan and his coworkers showed that an optimal cutoff value of 12mm of 
thrombus length in M1 segment occlusion was an independent predictor of recanalization success14. 
However, using SWI, Weisstanner found that the recanalization rate was not dependent on thrombus 
length in patients with anterior circulation stroke treated with EVT15. Additionally, in a larger cohort, 
Spiotta and his colleagues also observed no association between thrombus length and both likelihood 
of mechanical recanalization and clinical outcome in patients received EVT16. This “disputable” 
correlation has been seen in posterior circulation stroke as well. In BAO patients, Strbian reported 
recanalization success of basilar artery occlusion with IVT depends on thrombus length, although 
there was no threshold thrombus length2. However, no correlation was found between thrombus length 
and successful recanalization in a small cohort of BAO patients17. Undoubtedly, a longer thrombus is 
associated with reduced probabilities of reperfusion following IVT treatment although different or no 
cutoff values of thrombus length were foundNevertheless, the correlation between thrombus length 
and recanalization rate and clinical outcome in the acute stage of BAO remains uncertain. 
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As one of the thrombus imaging characteristics, thrombus density has emerged as a strong marker for 
predicting the likelihood of reperfusion in patients treated with IVT. However, findings on the 
relationship of thrombus density with recanalization rate and clinical outcome were contradictory. 
Some authors18-20 established that thrombi with lower density (in Hounsfield unit, HU) were more 
likely resistant to pharmacological lysis. Furthermore, hyperdense thrombi were also shown to 
associate with higher recanalization rates in patients treated with EVT21, 22. Other researchers did not 
find the same association neither in patients who received IVT14 or EVT16, 23. Additionally, thrombus 
density did not relate to long-term clinical outcome (90 days or 6-month follow-up) in patients treated 
with IVT according to others14, 24, 25. However, the relationship between thrombus density and clinical 
outcome still needs further determination. Although EVT was widely used for patients with large 
vessel occlusion in recent years, it still remains uncertain as to how key information about thrombus 
imaging characteristics might improve treatment decision-making as successful recanalization was 
independent of a high clot burden26. More substantial insights into thrombus composition or thrombus 
density should be given to determine therapeutic implications. Therefore, we aimed to evaluate the 
prognostic value of thrombus characteristics, including thrombus length and thrombus density, 
regarding recanalization rate and outcome in BAO patients treated with EVT.  
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Methods and Materials 
 
Patients 
The local institutional review board and ethic committee approved the study. We retrospectively 
studied consecutive patients with BAO treated with EVT between April 2007 and October 2015. 
Patients who underwent non-enhanced cranial CT (NECCT) scanning with thin-slice reconstructions 
before treatment were included (n=55). We excluded patients with significant artifacts in the initial 
NECCT images preventing thrombus evaluation (n=4). Therefore, our cohort comprises 51 BAO 
patients (Fig. 1). 
 
Clinical data 
The relevant demographic data and clinical data of all included patients were extracted from the 
patients’ charts and collected by a board-certified neurologist. Neurological disease severity at 
admission was scored using the National Institutes of Health Stroke Scale (NIHSS). The site of 
occlusion proven by Computed Tomography Angiography (CTA) was categorized as proximal 
[between the confluence of the vertebral arteries (VA) and the origin of the Anterior Inferior 
Cerebellar Artery (AICA)], mid [between the origin of the AICA and the origin of the Superior 
Cerebellar Artery (SUCA), but also any occlusion of more than one segment including mid-basilar)2], 
and top of the BA27. Time from onset to treatment (OTT) was defined as the interval between 
symptom onset to initiation of treatment. If the time of onset was unknown, the time that the patient 
was last seen asymptomatic was recorded. Stroke etiology was determined using the Trial of Org 
10172 in Acute Stroke Treatment (TOAST) classification28 and a standardized battery of test including 
follow-up brain imaging (CT and/or Magnetic Resonance Imaging (MRI)), cervical and intracranial 
vessel imaging (CTA, Magnetic Resonance Angiography (MRA) or ultrasound), 24h ECG Holter 
monitoring, transthoracic or transesophageal echocardiography and further laboratory tests as 
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clinically feasible and appropriate. Further relevant demographic data were extracted from the patients’ 
charts.  
 
Recanalization and outcome 
A neuroradiology fellow other than the performing neurointerventionalist blinded to clinical outcome 
interpreted recanalization success on digital subtraction angiography (DSA) images after the 
intervention. A TICI score of 2b-3 was defined as successful recanalization, and a TICI score of 0-2a 
was considered as no recanalization or unsuccessful recanalization2, 9, 29. Clinical outcome was 
evaluated using the modified Rankin scale (mRS) at 3 months either by face-to-face consultation or 
telephone interview. An mRS of 0 to 2 was defined as favorable outcome, whereas an mRS of 3-6 was 
defined as poor clinical outcome. 
 
Image acquisition, analysis and statistics 
Thrombus length 
NECCT 
Thrombi in the basilar artery were detected in all NECCT datasets (Brilliance 64, Philips, Best/The 
Netherlands, 120 kV, 320 mAs, reconstructed slice thickness 2.5mm). The clot length was calculated 
by one author as described previously30. In short, a region of interest (ROI) was defined in the course 
of a hyperdense vessel. All pixels between 55 and 80 HU served as a seed for a region-growing 
algorithm into adjacent pixels between 40 and 80 HU. Thrombus length was then calculated along the 
middle axis of this defined volume. The presence of a hyperdense basilar artery sign (HBAS) was 
rated by two independent raters. If disagreement was present a consensus was reached. Cohen’s κ was 
used to assess the agreement. 
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CTA 
CTA (80 kV, 280 mAs, 80 ml bolus of 350 mg I/ml, followed by a 40-ml saline flush at 5 ml/s) was 
available in 46 (90.2%) patients. Thrombus length, defined as an opacification gap on CTA, was 
determined by one investigator and checked for consistency by another, both blinded to thrombus 
length measurement on NECCT. A Bland-Altman plot was utilized to depict the consensus between 
thrombus length measurement by CTA and NECCT. 
 
Thrombus density 
First, two observers (one is an experienced neuroradiologist and the other a neuroradiology fellow) 
blinded to clinical data and read the whole series of images on thin-slice NECCT (reconstructed slice 
thickness 2.5 mm). Second, the HBAS was identified according to the following criteria, which are 
similar to those used for hyperdense middle cerebral artery sign (HMCAS) recognition31: 1) the whole 
axial view of the BA can be recognized easily; 2) attenuation of the vessel was higher than that of the 
surrounding tissue; 3) attenuation of the vessel was much higher than that of the vessel without 
hyperdense sign. Vessel wall calcifications (>100 HU) were excluded from the measurement. Third, 
the polygonal lasso tool (IMPAX workstation, Agfa Technical Imaging Systems) was utilized to place 
an Region of Interests (ROIs) encompassing within the whole hyperdense vessel slice by slice and 
ensure that the outline of the ROI would not surpass the margin of the thrombus (Fig. 2). Fourth, 
absolute HU values were calculated by adding the obtained HU values and then dividing by the 
number of observed slices. When available, CTA was used to localize the thrombus, especially a 
hypodense thrombus (n=9) (synchronous-localization function, Agfa Technical Imaging Systems). In 
order to correct the influence of hematocrit level on measurements, relative HU values were evaluated 
by using the HU ratio (HUclot / HUcontralateral). HUcontralateral for calibration was measured in a vessel 
proximal (intracranial vertebral artery or proximal basilar artery) or distal (distal basilar artery or 
posterior cerebral artery) to the clot20, 22, 32. 
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Statistics 
Statistical analysis was performed using SPSS software version 22 (IBM, NY). All continuous 
variables were first tested for normality using the Kolmogorov-Smirnov test. Variables with a normal 
distribution were noted as mean ± SD and were tested using an independent t-test. Mann-Whitney U 
test was used to analyze the variables without a normal distribution. To describe them, median value 
and the interquartile range (IQR) were calculated. Categorical variables are presented in numbers 
(percentage, %), and assessed using Fisher’s exact test. Spearman correlation test was used to evaluate 
the relationship between thrombus characteristics with OTT. Logistic regression analysis was 
performed to determine clinical factors, which might have a prognostic value regarding successful 
recanalization and favorable outcome. Statistical significance was set at p<0.05. 
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Figure 1. Study design and patient selection. 
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Figure 2. Example of the ROI definition. The outline was drawn along the 
boundary of the thrombus. This outline should not surpass the margin of the 
basilar artery, and any calcified plaque (HU >100) was excluded. This was 
repeated on every slice, the obtained HU values were added and then divided by 
the number of observed slices. 
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Results 
Fifty-one BAO patients treated with EVT were included in final analysis. EVT was started within 6 
hours after symptom onset in most cases (n=37/73%). EVT was performed using three different 
strategies: intra-arterial rtPA alone (5-80 mg, N=5), mechanical thrombectomy (n=30), and 
mechanical thrombectomy in combination with intra-arterial rtPA (n=16) (Table 1). IVT (0.9 mg 
rtPA/kg body weight) was delivered in 15.7% (n=8) of patients prior to EVT when proven BAO 
occurred within 4.5 h of symptom onset. Baseline characteristics and imaging-related factors of all 
patients are summarized in Table 2 and Table 3. 70.6% of the patients were male (n=36), median age 
was 72 years (66-78 years, IQR), and median NIHSS at admission was 18 (11-23points, IQR). There 
was no relationship between baseline NIHSS and recanalization rate. However, low baseline NIHSS 
was a strong predictive factor for favorable outcome (P=0.04). Median thrombus length measured on 
NECCT was 7.5 mm (5-14.4 mm, IQR). Absolute thrombus density was 51.6 ± 6.2 HU (mean value), 
whereas mean relative thrombus density was 1.34 ± 0.15. There was no correlation between thrombus 
length and density (P=0.16). CTA was utilized to determine the site of BA occlusion before treatment. 
Proximal BA occlusion was observed in 19.6% (n=10) while mid-BA occlusion was 41.2% (n=21) 
and top of BA occlusion was 39.2% (n=20). No evidence was found in support of a different site of 
occlusion being relevant to recanalization rate or clinical outcome (Table 2 and 3). In 42 patients 
(82.4%) HBAS was present (Cohen’s κ = 0.74, Table 4). Median time from onset to treatment (OTT) 
was 222 min (178-462 min, IQR). Shorter OTT showed a trend, but not a statistically significant 
difference towards higher recanalization rate (P=0.13), whereas no relationship was found between 
OTT and clinical outcome. Neither the presence of a HBAS nor OTT was correlated with 
recanalization and outcome. In the Spearman correlation test, neither thrombus length nor thrombus 
density was correlated with OTT (Fig.3 and 4). BAO patients only treated with IAT tended to hardly 
achieve successful recanalization (P=0.04). However, the population was quite small (n=5 and 
successful recanalization was only in one patient). Bland-Altman plot demonstrated a good agreement 
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between thrombus length measured on NECCT and on CTA (Fig. 5). Interestingly, the thrombi of the 
three patients whose data points were outside the limits of agreement, proved to be of heterogeneous 
composition (Fig. 6). Stroke etiology was cardiogenic (58.5%, N=30), atherosclerotic large artery 
(25.5%, N=13), other confirmed (9.8%, N=5), and unknown (5.9%, N=3) according to TOAST 
criteria28.  
 
Recanalization 
Successful recanalization was achieved in 34 patients (66.7 %). In forty-six patients, first-generation 
mechanical devices (such as Penumbra) were applied in 30.4% (n=14), whereas second-generation 
devices (e.g. stent retrievers such as Trevo or Solitaire) were used in 69.6% (n=32) (one device alone 
or in combination with other devices). In seven patients (21.8%) no or minimal recanalization was 
achieved. In one patient (3.1%) the exact number of passes was not documented. For the remaining 
twenty-four patients, we did not find a correlation between thrombus density and number of 
stent-retriever passes (P=0.197). However, there was a trend towards longer thrombus needed more 
number of stent-retriever passes (r=0.37, P=0.08). The recanalization rate in our study is slightly 
lower than those established in other studies8, 17. However, after dichotomizing our series according to 
mechanical devices used for patients, we found that recanalization was achieved in 78.1% of patients 
treated with stent retrievers (n=32) and in 57.1% of patients in whom stent retrievers were not applied 
(n=14). Favorable clinical outcome was reached by 13 patients (25.5%) and moderate clinical outcome 
(90 days mRS 0-3) was in 18 patients (35.3%). Mortality was 37.3% (n=19) (Table 5). In univariate 
analysis, thrombus length measured on NECCT or CTA showed no significant difference between 
patients with (n=34/66.7%) or without (n=17/33.3%) successful recanalization (7.9 mm vs. 7.5mm, 
P=0.94) (Table 2 and Fig. 7). In univariate analysis, absolute thrombus density showed a trend toward 
higher recanalization rate (P=0.08) (Table 2). However, relative thrombus density showed no 
statistically significant correlation with successful recanalization (P=0.11) (Fig. 9). Other clinical 
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variables did not have a correlation with successful recanalization as well. In binary logistic regression 
analysis, neither recanalization rate nor clinical outcome showed a significant association with 
thrombus length (odds ratio [OR] 1.03, 95% confidence interval [CI] 0.97-1.10, P=0.37; OR 0.94, 95% 
CI 0.86-1.03, P=0.20, respectively, Table 6). 
 
Clinical Outcome 
Favorable outcome was observed in 13 patients (25.5%). There was no difference of thrombus lengths 
between patients with and without favorable outcome (7.3 mm vs. 8.3 mm, P=0.23, Table 3 and Fig. 
8). In univariate analysis, absolute thrombus density was statistically different between patients with 
(n=13/25.5%) and without (n=38/74.5%) favorable outcome (55.7 HU vs. 50.1 HU, P=0.004) (Table 
3 and Fig. 10). This statistically significant difference was also present when relative thrombus density 
was compared (1.49 vs. 1.28, p<0.001). In a secondary analysis, no differences were found in absolute 
thrombus density when patients with local atherosclerotic changes were compared to those without 
(51.0 ± 7.0 v. 51.8 ± 5.9, P=0.70) and there was no difference regarding recanalization rates (P=0.25) 
or clinical outcomes (P=0.73). This statistically significant difference was also present when relative 
thrombus densities were compared (1.49 vs. 1.28, p<0.001). All patients without a HDBAS showed 
poor outcome (n=13/100%) even though no statistical difference was found (P=0.09). In the logistic 
regression analysis, thrombus length did not show a correlation with favorable outcome (OR 0.94, 95% 
CI 0.86-1.03, P=0.20). However, high density of thrombi was a significant predictor of favorable 
outcome (OR 1.31, 95% CI 1.08-1.59, P=0.006) (Table 3 and Fig. 10). Symptomatic intracranial 
hemorrhage per ECASS II33 occurred in five patients (9.8%) (three patients with SAH and two patients 
with PH I) and all of them (100%) showed poor outcome. There was a strong association between 
successful recanalization and favorable outcome (P=0.04) (Table 3). 
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Table 1. Treatment strategy and devices. 
 
Treatment strategy n (%) 
IAT only 
Mechanical thrombectomy only 
IVT + Mechanical thrombectomy 
IAT + Mechanical thrombectomy 
IVT + IAT + Mechanical thrombectomy 
Overall 
5 (9.8%) 
23 (45.1%) 
7 (13.7%) 
15 (29.4%) 
1 (2.0%) 
51 
Devices   
Mechanical thrombectomy 
Trevo 
Penumbra 
Solitaire 
Trevo + Solitaire 
Trevo + Penumbra 
Other 
30 (58.9%) 
15 (29.4%) 
4 (7.8%) 
3 (5.9%) 
3 (5.9%) 
2 (3.9%) 
3 (5.9%) 
Mechanical thrombectomy + IAT 
Penumbra + IAT 
Trevo + IAT 
Solitaire + IAT 
Other + IAT 
16 (31.4%) 
9 (17.6%) 
4 (7.8%) 
2 (3.9%) 
1 (2.0%) 
Stent 
“Coronary Integrity” 
 
5 (9.8%) 
Mechanical devices 
  First-generation 
  Second-generation 
46 (90.2%) 
14 (30.4%) 
32 (69.6%) 
Overall 51 
IVT: Intravenous thrombolysis with recombinant tissue plasminogen activator. 
IAT: Intra-arterial thrombolysis with recombinant tissue plasminogen activator. 
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Table 2. Baseline characteristics of BAO patients with regard to recanalization. 
 
 
Characteristics 
Overall 
(n=51) 
No or unsuccessful 
recanalization 
TICI 0-2a (n=17) 
Successful 
recanalization 
TICI 2b-3 (n=34) 
 
P Value 
Age, yrmedian (IQR) 72 (66-78) 73 (61-83) 72 (67-76) 0.42 
Male, n (%) 36 (70.6) 13 (76.5) 23 (67.6) 0.75 
Baseline NIHSS, median (IQR) 18 (11-23) 18 (16-24) 17 (10-20) 0.30 
Site of occlusion     
 Proximal BA, n (%) 10 (19.6) 3 (17.6) 7 (20.6) 1.00 
 Mid BA, n (%)  21 (41.2) 7 (41.2) 14 (41.2) 1.00 
 Top of BA, n (%) 20 (39.2) 7 (41.2) 13 (38.2) 1.00 
Thrombus length, mm, median (IQR) 7.5 (5-14.4) 7.5 (6.5-11.5) 7.9 (5-16.2) 0.94 
Density, absolute HU 51.6 ± 6.2 49.2 ± 6.8 52.7 ± 5.6 0.08 
Density, relative HU 1.34 ± 0.15 1.29 ± 0.13 1.36 ± 0.16 0.11 
HBAS, n (%) 42 (82.4) 13 (76.5) 29 (85.3) 0.46 
Onset-to-treatment, min, median (IQR) 222 (178-462) 205 (184-803) 221 (165-365) 0.68 
Strategy of EVT     
I.A. rtPA only, n (%) 5 (9.8) 4 (23.5) 1 (2.9) 0.04 
Mechanical only, n (%) 30 (58.9) 8 (47.1) 22 (64.7) 0.25 
Mechanical + I.A. rtPA, n (%) 16 (31.4) 5 (29.4) 11 (32.4) 1.00 
Etiology     
Cardioembolic, n (%) 30 (58.8) 11 (64.7) 19 (55.9) 0.76 
Large artery atherosclerotic, n (%) 13 (25.5) 3 (17.6) 10 (29.4) 0.50 
Other confirmed etiology, n (%) 5 (9.8) 2 (11.8) 3 (8.8) 1.00 
Unknown, n (%) 3 (5.9) 1 (5.9) 2 (5.9) 1.00 
IQR: interquartile range; NIHSS: National Institutes of Health Stroke Scale scores; BA: basilar artery; HBAS: 
hyperdense basilar artery sign; I.A.: intra-arterial; rtPA: recombinant tissue plasminogen activator. 
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Table 3. Baseline characteristics of BAO patients with regard to outcome. 
 
 
Characteristics 
Overall 
(n=51) 
Poor outcome 
3-mo mRS 3-6 
   (n=38) 
Favorable outcome 
3-mo mRS 0-2 
   (n=13) 
 
P Value 
Age, yr, median (IQR) 72 (66-78) 71 (66-80) 73 (67-74) 0.72 
Male, n (%) 36 (70.6) 28 (73.7) 8 (61.5) 0.49 
Baseline NIHSS, score, median (IQR) 18 (11-23) 18 (16-23) 15 (9-19) 0.04 
Site of occlusion     
 Proximal BA, n (%) 10 (19.6) 9 (23.7) 1 (7.7) 0.42 
 Mid BA, n (%)  21 (41.2) 16 (42.1) 5 (38.5) 1.00 
 Top of BA, n (%) 20 (39.2) 13 (34.2) 7 (53.8) 0.32 
Thrombus length, mm, median (IQR) 7.5 (5-14.4) 8.3 (6-15.6) 7.3 (4.9-10.3) 0.23 
Density, absolute HU 51.6 ± 6.2 50.1 ± 6.1 55.7 ± 4.3 0.004 
Density, relative HU 1.34 ± 0.15 1.28 ± 0.12 1.49 ± 0.12 <0.001 
HBAS, n (%) 42 (82.4) 29 (76.3) 13 (100) 0.09 
Onset-to-treatment, min, median (IQR) 222 (178-462) 221 (183-479) 244 (175-515) 0.90 
Strategy of EVT     
I.A. rtPA only, n (%) 5 (9.6) 5 (12.8) 0 (0) 0.31 
Mechanical only, n (%) 30 (57.7) 22 (56.4) 8 (61.5) 1.00 
Mechanical + I.A. rtPA, n (%) 16 (32.7) 12 (30.8) 5 (38.5) 0.73 
Etiology     
Cardioembolic, n (%) 30 (58.8) 23 (60.5) 7 (53.8) 0.75 
Large artery atherosclerotic, n (%) 13 (25.5) 9 (23.7) 4 (30.8) 0.72 
Other confirmed etiology, n (%) 5 (9.8) 4 (10.5) 1 (7.7) 1.00 
Unknown, n (%) 3 (5.9) 2 (5.3) 1 (7.7) 1.00 
sICH per ECASS II, n (%) 5 (9.8) 5 (13.2) 0 0.31 
Recanalization, TICI 2b-3, n (%) 34 (66.7) 22 (57.9) 12 (92.3) 0.04 
IQR: interquartile range; NIHSS: National Institutes of Health Stroke Scale score; mRS: modified Rankin Scale; 
BA: basilar artery; HBAS: hyperdense basilar artery sign; I.A.: intra-arterial; rTPA: recombinant tissue 
plasminogen activator; sICH: symptomatic intracranial hemorrhage; ECASS: European Cooperative Acute 
Stroke Study. 
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Figure 3. No correlation between thrombus length and time from onset to 
treatment. 
 
 
Figure 4. No correlation between thrombus density and time from onset to 
treatment. 
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Figure 5. Bland-Altman plot demonstrates a good agreement between the 
reference thrombus lengths measured on CT angiography (TLCTA) and thrombus 
lengths measured on non-enhanced cranial CT (TLNECCT). TL: thrombus length 
(in mm). 
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Figure 6. Heterogeneous thrombus. NIHSS 30 at admission. A, B: A hypodense 
thrombus is present in the midbasilar level, a hyperdense thrombus in the 
proximal basilar artery. C, D: CTA demonstrates multi-segmental occlusion. 
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Table 4. Inter-rater coefficient of HBAS identification. 
 
  Observer 2 Cohen’s 
κ   HBAS present HBAS absent 
Observer 1 
HBAS present 37 5 
0.74 
HBAS absent 0 9 
 
 
 
Table 5. Clinical outcome data. 
 
 
No recanalization 
TICI 0-2a, n=17 
Successful 
recanalization 
TICI 2b-3, n=34 
P value 
sICH per ECASS II, n (%) 5 (29.4) 0 0.003 
90 days mRS 0-2, n (%) 1 (5.9) 12 (35.3)) 0.04 
90 days mRS 0-3, n (%) 1 (5.9) 17 (50) 0.002 
90 days mortality, n (%) 10 (58.8) 9 (26.5) 0.034 
sICH: symptomatic intracranial hemorrhage. ECASS: European Cooperative Acute Stroke Study. mRS: 
modified Rankin Scale. 
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Table 6. Logistic regression for successful recanalization and favorable 
outcome. 
 
Predictive 
Factors 
      Odds Ratio 
(95% Confidence Interval) 
 
P Value 
Successful Recanalization   
Thrombus Length 1.03 [0.97-1.10] 0.37 
Thrombus Density 1.10 [0.99-1.22] 0.06 
Favorable Outcome   
Thrombus Length 0.94 [0.86-1.03] 0.20 
Thrombus Density 1.31 [1.08-1.59] 0.006 
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Figure 7. Bar graph illustrates recanalization rate and 95% confidence interval 
of BAO patients regarding different thrombus lengths. 
 
 
Figure 8. Bar graph demonstrates favorable outcome rate and 95% confidence 
interval of BAO patients regarding different thrombus lengths. 
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Figure 9. Bar graph demonstrates a trend towards higher density of the 
thrombus correlated with higher recanalization rate. (HU: Hounsfield units.).  
 
Figure 10. Bar graph demonstrates increasing rate of favorable outcome with 
higher density of the thrombus. (HU: Hounsfield units). 
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Discussion 
In this study, we analyzed the dependency of thrombus properties for recanalization rate and clinical 
outcome in 51 patients with acute occlusion of the basilar artery treated with endovascular therapy. 
The main results are twofold. First, successful recanalization was independent of thrombus length. The 
effectiveness of EVT is well documented and was reported to range from 68-82%10, 34-37 even with a 
high clot burden38. This is different in patients treated with IVT. Our previous study12 suggested that 
patients with MCA occlusion rarely benefited from IVT if the length of thrombi exceeded 8 mm. 
Strbian and coworkers demonstrated that the recanalization rate of BAO patients after IVT was 
dependent on thrombus length although no threshold could be established beyond which IVT was 
deemed futile. Similar to our results, Gilberti and colleagues reported that recanalization is 
independent of thrombus length in BAO treated with EVT17. However, they determined thrombus 
length on DSA, whereas we measured thrombus length on initial NECCT.  
 
Contrary to the result that long thrombi showed a linear association with poor outcome17, we did not 
observe the same correlation in this study. In the ENDOSTROKE registry, the authors found that 
baseline NIHSS and collateral status were significant predictors of clinical outcome8. However, the 
relationship between imaging markers and clinical outcome was not evaluated. Thus, a large trial is 
still needed to validate the influence of thrombus length on clinical outcome. 
 
During the past few years, thrombus length was considered as a useful predictor of recanalization rate 
and outcome but the results remain controversial (Table 7).  
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Indeed, several points require special interpretation. First, some of these studies measured thrombus 
length on CTA images. However, the contrast gap as assessment of clot burden on CTA images 
depends both on clot length and the status of the pial collaterals39. Regularly, the distal end of a clot 
will be delineated less clearly than the proximal face. This implies that clot length might be 
overestimated on CTA images if the vasculature back to the distal clot face was very blurry due to a 
poor leptomeningeal collateral. Secondly, measuring thrombus length on Susceptibility Weighted 
Imaging (SWI) images relies on determining the Susceptibility Vessel Sign (SVS). However, the 
accuracy of quantification is limited by blooming artifacts and a large variation in sensitivity of SVS. 
These aspects might explain why these studies came to different conclusions by using same imaging.
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Table 7. Thrombus length and its correlation with recanalization rate and clinical outcome established in recent major studies. 
 Modality 
Slice 
thickness 
Treatment 
Site of 
occlusion 
Mean or median 
length of thrombi 
Correlation with recanalization 
Threshold of thrombus 
length as a predictor of 
successful recanalization 
Correlation with outcome 
Riedel et al.12 
(n=138) 
NECCT 2.5 mm IVT 
Anterior 
circulation 
NR 
Longer thrombus correlated with 
lower recanalization rate 
8 mm N/A 
Kamalian et 
al.11 (n=53) 
NECCT 0.625 mm IVT 
Anterior 
circulation 
18.5 mm 
Longer thrombus correlated with 
lower recanalization rate 
8 mm N/A 
Rohan et al.36 
(n=80) 
CTA 2 mm, MIP IVT 
Anterior 
circulation 
M1: 12.7 mm 
M1/M2: 15.4 mm 
Longer thrombus correlated with 
lower recanalization rate 
12 mm 
Longer thrombus correlated 
with worse clinical outcome 
Yan et al.40 
(n=74) 
dGE-T1, 
MRI 
5mm - 20 
mm 
IVT 
Anterior 
circulation 
8.18 mm 
Longer thrombus correlated with 
lower recanalization rate 
14 mm N/A 
Strbian et al.2 
(n=140) 
CTA NR IVT 
Posterior 
circulation 
Median: 10 mm 
Mean: 12 mm 
Longer thrombus correlated with 
lower recanalization rate 
N/A N/A 
Spiotta et al.16 
(n=141) 
CTA 2 mm, MIP EVT NR 13.3 ± 9.5 mm No correlation N/A No correlation 
Weisstanner et 
al.15 (n=88) 
GE-MRA 0.9 mm EVT 
Anterior 
circulation 
10.9 mm No correlation N/A N/A 
Jindal et al.41 
(n=28) 
SWI 1 mm EVT 
Anterior 
circulation 
19 ± 7 mm No correlation N/A N/A 
Gilberti et 
al.17(n=32) 
DSA NA EVT 
Posterior 
circulation 
NR No correlation N/A 
Longer thrombus correlated 
with worse clinical outcome 
N/A: not applicable. 
NR: not reported. 
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Recently, Yan et al. demonstrated the response to alteplase in MCA occlusion patients by measuring 
thrombus length on delayed gadolinium-enhanced (dGE) T1 MRI images40. This special method 
measures thrombus length more accurately than SWI does. The authors introduced a novel approach to 
demarcate the distal face of the thrombus clearly on magnetic resonance angiography (MRA) images 
using dGE T1 sequences although collateral flow was poor in these patients. However, this particular 
method is not part of a routine scan in clinical practice. Moreover, the application of this special dGE 
T1 sequence would be limited by difficulties in accessing MRI in a timely fashion in many clinical 
centers. Nowadays, a slice thickness less than 1 mm can be achieved with modern multi-detector CT 
scanners so that clot length can be reliably determined and visualized without interference from partial 
volume effects42. Only a few seconds of additional reconstruction time was needed and time was saved 
for urgent treatment rather than long acquisition duration of a MR protocol. In our series, we evaluated 
thrombus length on thin-slice NECCT images based on excellent agreement with identification of 
HBAS (Table 4). The Bland-Altman plot demonstrated a great consensus between thrombus length 
measured on NECCT and on CTA. Interestingly, the thrombi of the three patients whose data points 
were outside the limits of agreement proved to be of heterogeneous composition (Fig. 6). Usually we 
registered thrombus segmentation on NECCT images according to HBAS, which would commonly 
show a “mismatch” of clot length estimation between thrombus with low density or a heterogeneous 
component and that with high density. 
 
The second finding of our study is that high-attenuating thrombi correlated with better clinical 
outcome. Several previous studies had already demonstrated that a thrombus with higher density was 
associated with better recanalization rates either by IVT or EVT (Table 8). However, this finding is in 
dispute. Yilmaz23 reported on 70 patients treated with EVT and thrombus density did not predict 
recanalization success. It is widely accepted that erythrocyte-rich clots show a higher density than 
platelet-rich thrombi on NECCT43-45. It was accordingly claimed that erythrocyte-rich clots with low 
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fibrin content are more amenable to pharmacological46 and mechanical therapy44. However, we did not 
find a correlation with recanalization rate but rather with clinical outcome. We hypothesized that 
low-attenuating thrombi might be caused by atherosclerotic changes (Fig. 11) and partial volume 
effects may have blurred high-attenuating thrombi but our secondary analysis did not substantiate this 
hypothesis. Patients with atherosclerotic changes in the basilar artery did not have lower-attenuating 
thrombi nor did they experience lower recanalization rates and clinical outcome. 
 
There are several reasons why the influence of thrombus density on clinical outcome and 
recanalization rate should be regarded with caution. First, in the posterior circulation -- especially in 
the basilar artery – beam-hardening artifacts caused by the temporal bones and vessel calcifications 
are fairly common and may substantially alter density measurements. Secondly, there is no standard 
procedure to measure thrombus density and results are thus more or less subjective. Thirdly, since a 
high hematocrit level influences the accuracy of thrombus density measurement, this effect needs to be 
calibrated. However, it is difficult to choose the same vessel as a reference, such as the contralateral 
MCA: for instance, if the mid-BA was occluded, the VA or the top of the BA or even the PCA would 
be considered as the “vessel on contralateral side” for calibration. This kind of uncertainty might 
render a thrombus density estimation less accurate. In addition, the validation of this method should be 
evaluated. In summary, more sophisticated and standardized methods to measure thrombus density, 
including filtering, might be needed47 
 
In contrast to anterior circulation stroke, recanalization did not automatically translate into good 
clinical outcome. We thus suggest that thrombus length may not be the pivotal factor when it comes to 
clinical outcome. Patients should be treated irrespectively of thrombus length with the treatment 
modality according to national or local guidelines.
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Table 8. Thrombus density and its correlation with recanalization rate and clinical outcome established in recent major studies. 
 
 
Treatment 
Site of 
occlusion 
Different methods used 
for thrombus density 
measurement 
Absolute HU Relative HU 
Correlation with 
recanalization 
Correlation 
with outcome 
Kim EY et 
al.18 (n=51) 
IVT 
Anterior 
circulation 
One ROIs around the 
margin of the thrombi 
51.4 HU 1.33 
Lower HU of thrombi was 
more likely resistant to 
alteplase (relate to lower 
recanalization rate) 
N/A 
Puig et al.20  
(n=87) 
IVT 
Anterior 
circulation 
One ROIs around the 
margin of the thrombi 
50 (recanalization 
group) and 42 
(persistent occlusion 
group) 
1.57 (recanalization 
group) and 1.11 
(persistent occlusion 
group) 
Higher HU of thrombi 
correlated with higher 
recanalization rate 
N/A 
Rohan et 
al.14 (n=80) 
IVT 
Anterior 
circulation 
One small round ROIs 
throughout the occluded 
artery 
64 HU 1.26 No correlation No correlation 
Niesten et 
al.19 (n=88) 
IVT 
Anterior 
circulation 
Three small round ROIs 
within the thrombi 
(mean value) 
63.1 HU (recanalization 
group) and 52.2 HU (no 
recanalization group) 
1.54 (recanalization 
group) and 1.29 (no 
recanalization group) 
Lower absolute HU and 
relative HU related to 
lower recanalization rate 
N/A 
Mair et al.24 
(n=109) 
IVT 
Anterior 
/Posterior 
circulation 
One ROIs in the 
thrombi 
51.0 HU 1.38 N/A No correlation 
Topcuoglu 
et al.25 
(n=105) 
IVT or IA. 
rtPA 
Anterior 
circulation 
/vertebrob
asilar 
stroke 
One voxel-sized ROIs 
over occluded artery 
47.4 HU (favorable 
outcome group) and 
49.4 HU (poor outcome 
group) 
1.13 HU (favorable 
outcome group) and 1.17 
HU (poor outcome group) 
N/A No correlation 
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Moftakhar 
et al.32 
(n=90) 
IVT alone, 
EVT alone 
and EVT 
followed 
with IVT 
Anterior 
circulation 
Basilar 
artery 
One ROIs around the 
margin of the thrombi 
N/A 
1.58 in patients with IV 
rtPA; 1.66 in patients with 
IA rtPA; 1.7 in patients 
with EVT in successful 
recanalization group, 
Lower HU of thrombi 
tended to be resistant to 
alteplase (relate to lower 
recanalization rate after 
both IVT and EVT) 
N/A 
Froehler et 
al.21 (n=67) 
EVT 
(MERCI 
device) 
Anterior 
circulation 
/Basilar 
artery 
Three circular or oval 
ROIs within the thrombi 
(mean value) 
N/A 
1.46 in patients with 
hyperdense vessel sign 
and 
1.03 in patients with 
hypodense vessel sign 
Hyperdense thrombi 
correlated with successful 
recanalization 
N/A 
Yilmaz et 
al.23 (n=70) 
EVT 
Anterior 
circulation 
ROIs were placed 
perpendicular to the 
vessel on sagittal 
reconstructions of 
NECCT 
50.1 HU (recanalization 
group) and 48.7 HU (no 
recanalization group) 
N/A No correlation N/A 
Spiotta et 
al.16 
(n=141) 
EVT NR 
One round ROIs which 
cover the most-dense 
part of the whole 
thrombi in three slices 
(mean value) 
59.9 HU N/A No correlation No correlation 
Mokin et 
al.22 (n=41) 
EVT 
Anterior 
circulation 
One ROIs around the 
margin of the thrombi 
49.9 HU (recanalization 
group) and 43.8 HU (no 
recanalization group) 
1.2 (recanalization group) 
and 1.0 HU (no 
recanalization group) 
Higher absolute and 
relative HU of thrombi 
correlated with higher 
recanalization 
N/A 
N/A: not applicable. 
NR: not reported
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Figure 11. Severe atherosclerotic changes in a 69-year-old male with NIHSS 30 
at admission. A. Hyperdense thrombus with hypodense rim in the mid-basilar 
artery on NECCT. B. CTA demonstrates complete occlusion of the basilar artery. 
C. DSA image demonstrates severe atherosclerotic changes in the basilar artery.  
 
 
Four patients in our cohort were excluded from this study because of substantial artifacts that 
prevented us from measuring thrombus length and density. After including their OTT into a secondary 
analysis, patients whose OTT was less than 3 hours were more likely to achieve successful 
recanalization than those more than 3 hours (Fig. 12). Our result is in line with that of Sheth48 who 
reached the same conclusion after further analysis of the SWIFT and STAR trials. For acute ischemia 
stroke patients, although effective second-generation mechanical devices were widely used, several 
minutes’ delay in EVT would result in a worse clinical outcome. 
 
This study has some limitations. The retrospective nature of the study and limited sample size (Type II 
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error) does not allow for generalization of our results. Further, the study period from 2007-2015 limits 
the comparability of devices used as the effectiveness dramatically changed. In our cohort, we 
achieved a higher rate of recanalization with second generation devices (n=32) of 78.1 % as compared 
to 57.1 % with first generation devices (n=14) (Table 9). In addition, we did not evaluate every 
possible variable such as collateral status, medical history, etc. that may be predictive of recanalization 
and outcome. Furthermore, considering the limited number of patients, multi logistic model were not 
used for further analysis of independent predictive value of thrombus density toward favorable 
outcome. Four patients in our cohort were excluded from this study because of substantial artifacts 
preventing thrombus length and density measurement. With regard to their successful recanalization 
and poor clinical outcome, the relationship between thrombus properties and recanalization and 
outcome might be underestimated. 
 
Conclusions 
Successful recanalization with EVT can be achieved despite a high clot burden in patients with acute 
occlusion of the BA. High density of thrombi seems to be a predictor of better clinical outcome. 
Standardized methods to measure thrombus density are needed. 
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Table 9. Difference between first-generation and second-generation mechanical 
devices regarding recanalization rate. 
 
 
Mechanical devices 
Overall 
(n=46)* 
No or partial 
recanalization 
TICI 0-2a  
(n=13) 
Successful 
recanalization 
TICI 2b-3  
(n=33) 
 
P Value 
First-generation (non-stent retrievers), n (%) 14 (30.4) 6 (46.2) 8 (24.2) 0.17 
Second-generation (stent retrievers), n (%) 32 (69.6) 7 (53.8) 25 (75.8)  
Thrombus length in patients with non-stent 
retrievers, mm, median (IQR) 
 7.5 (6.1-8.1)  5 (4.3-6.9) 0.11 
Thrombus length in patients with stent 
retrievers, mm, median (IQR) 
 8.6 (6.4-20.9) 11.2 (6.5-24.2) 0.75 
*5 patients received intra-arterial thrombolysis only. 
 
 
Figure 12. Recanalization rate in patients whose OTT less than 3 hours was 
significantly higher than in those in whom it was more than 3 hours. 
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PART II Thrombus density measurements on non-enhanced cranial 
computed tomography: comparison of three methods 
 
Introduction 
In basilar artery occlusion (BAO) patients, early diagnosis and rapid, successful reperfusion are the 
primary goals of therapy. Since successful recanalization was achieved in 50–70% BAO patients 
treated with IVT9, 49, 50. Recently, mechanical treatment or bridging therapy (IVT is administered 
before IAT or thrombectomy or both) was explored further. However, neuroimaging markers valuable 
in acute ischemic stroke for selecting efficient and appropriate treatment necessitate further 
investigation. Although numerous prognostic factors have emerged, few of those provided information 
for improving the decision-making with regard to treatment26. Previous studies focused on the 
estimation of clot length or volume wherein, a long thrombus was considered to correlate with a low 
rate of recanalization2, 12, 14, 17, 51. Interestingly, a certain proportion of short thrombi needed more 
thrombectomy maneuvers during the intervention than those with identical length. This implies that 
additional thrombus characteristics, such as thrombus histopathological composition, were essential.  
 
HBAS is a visual marker of BAO on NECCT images52. Although the specificity is high, the sensitivity 
of HBAS is low. The hyperdense vessel sign indicated a high likelihood of arterial obstruction when 
observed on NECCT images; whereas its absence indicated only 50% arterial patency24. However, 
thin-slice NECCT scan supported by modern multi-detector CT may improve the detection of the 
hyperdense vessel sign42. Ernst et al. found that approximately 90% sensitivity of HBAS can be 
achieved by the combination of a cut-off visual value of 46.5 HU (absolute HU) or 1.32 ratio (absolute 
HU/hematocrit level) on thin-slice volumetric NECCT53. Owing to the reliable function of qualitative 
identification, HBAS might be a valuable tool in quantitatively measuring the density of the thrombus. 
Notably, some studies found that a higher density of thrombi was associated with a higher probability 
Part II                                                                                   34 
		
of recanalization18-20, 22, 32, which could not be confirmed by other studies14, 16, 23.  
 
In all the studies described above, these controversial results might be attributed to different methods 
used for the measurement of the thrombus density. The most widely used methods based on ROI are 
as follows: 1) Placing one circular ROI in the dense part (usually exhibiting the most intense signal) of 
the thrombi16, 18. 2) Placing multiple (usually three) circular ROIs into the hyperdense vessel19, 21. 3) 
Placing multiple irregular ROIs encompassing the whole hyperdense vessel slice-by-slice20, 54. 
Although all three methods above were commonly used in most studies, there is no doubt that the 
single mean/median value of the thrombus density calculated from the measurements of one or 
multiple ROIs could not represent the real density of the whole thrombus, especially when the 
composition of the thrombus was heterogeneous. Therefore, in this study, the density of the thrombus 
in BAO patients was compared among these three different methods. We hypothesized that these 
methods yield significantly different results and might preclude the comparison among studies 
conducted with different methods, and the whole thrombus density measurements could provide 
additional information about the composition of the thrombus. 
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Methods and Materials 
Patients 
The study was approved by the local ethics committee. Consecutive patients with basilar artery 
occlusion receiving EVT between April 2007 and October 2015 were studied retrospectively. All 
BAO patients who underwent thin slice non-enhanced cranial CT (NECCT) (Brilliance 64, Philips, 
Best/The Netherlands, 120 kV, 320 mAs, reconstructed slice thickness 2.5mm) prior to mechanical 
thrombectomy were included (n=36). Patients whose initial NECCT presented significant artifacts 
preventing thrombus density evaluation were excluded (n=2). In addition, patients with unavailable 
CTA scan (n=5) or DSA images showing severe atherosclerotic changes (n=5) were also excluded. 
Subsequently, two commonly used methods for density measurement and density distribution of the 
whole thrombus were performed in 24 patients sorted alphabetically to avoid selection bias (Fig. 1).  
 
Clinical data 
Demographics data and other baseline characteristics (initial NIHSS, recanalization rate, and outcome) 
were evaluated according to the criteria described in Part 1. 
 
Image acquisition 
Three different methods for thrombus density assessment 
Method 1: The whole hyperdense vessel encompassed within a ROI. 
In order to determine the density distribution of the whole thrombus, we evaluated thrombus density 
by using a ROI encompassed the whole hyperdense vessel slice by slice. In the case of thrombi with 
high density (HBAS present), first, the thrombus was detected on thin-slice NECCT images according 
to HBAS (Fig. 2A). Second, these NECCT raw images were imported into Image J (National 
Institutes of Health, https://imagej.nih.gov/ij/). Third, polygonal lasso tool of Image J was used to 
place the consecutive multiple dots encompassing the margin of the whole hyperdense thrombus on 
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every slice in which thrombus could be identified. (Fig. 2B). Fourth, the bin values of all pixels within 
the ROIs were automatically recorded by Image J and converted into independent datasets. For 
thrombi with low density (HBAS absent), the following steps were performed. First, CTA images 
(reconstruction slice thickness 2 mm) were utilized to co-localize with the thrombus in all 
corresponding NECCT slices (IMPAX workstation, Agfa Technical Imaging Systems) (Fig. 3). 
Second, the polygonal selection tool (IMPAX workstation) was used to define all ROIs on these 
NECCT images (Fig. 2A). Third, steps two to four are repeated to ensure that the borderline of all 
ROIs defined by Agfa Imaging systems well-overlapped with those defined by Image J (Fig. 2C). In 
the end, the whole thrombus density measurements were calculated by using the independent datasets 
and represented as density distribution graph (Fig. 4). For thrombi that could be detected in several 
consecutive slices, thrombus density was determined by adding the density values of the ROIs divided 
by the number of the slices. All independent datasets representing the density distribution of the whole 
thrombus in every slice were combined and merged into integrated distribution. 
 
Method 2: Three circular ROIs placed into the most hyperdense appearing part of the vessel. 
The second method was performed by placing multiple (usually three) circular ROIs into the 
hyperdense vessel. First, step one and two performed in Method 1 were repeated. Second, three 
circular ROIs were placed using the oval tool of Image J (Fig. 5). In the event that the thrombi could 
be detected in only one slice, three ROIs would be defined in the same slice. The overlap of any two 
ROIs should be prevented and the borderline should not surpass the margin of the thrombi. For 
thrombi that could be detected in any two consecutive slices, two ROIs would be defined in one slice 
and the third ROI would be defined in the other. The long thrombi that could be detected in three or 
more consecutive slices, all the ROIs would be defined slice-by-slice. Third, the density of the 
thrombus was described as the mean/median value of three or more ROIs in all corresponding slices. 
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Method 3: One circular ROIs placed into the most hyperdense appearing part of the vessel. 
The third method for thrombus density measurement was performed similarly by placing a large 
circular region of interest into the most hyperdense-appearing part of the vessel (commonly with the 
most intense signal) (Fig. 5). If the thrombus could be detected on several consecutive slices, the 
maximum HU value among those derived from all slices would be considered as thrombus density. 
 
Absolute and relative thrombus density 
In order to achieve consistency in the quantitative measurements, one investigator defined ROIs with 
three different methods described above and evaluated both absolute thrombus density and relative 
thrombus density in all the 24 BAO patients. The absolute density was determined by the method 
discussed above. A second reader, blinded to the results of the first investigator, redrew 50 randomly 
selected ROIs. The mean density difference was 2.8 ± 1.2 HU. Thus, only the ROIs, defined by the 
first investigator, were used for subsequent analysis. The three different methods discussed above 
were repeated in the normal-appearing contralateral or distal/proximal artery (HUcalibration) in all 24 
BAO patients. The relative density was calculated with HUthrombus / HUcalibration described in Part I. 
 
Statistics 
Normally distribution was assessed by the Kolmogorov–Smirnov test. Both density distribution of the 
whole thrombus method and density derived from the two other methods were expressed by the mean 
value (standard deviation, SD) and median value (interquartile range, IQR). The difference in the 
densities among different methods was expressed as the median value. To evaluate the difference in 
the density distributions of the whole thrombus method as compared to the measurements from the 
other methods, Mann–Whitney U test was used. Prism GraphPad software 6.0 (GraphPad Software 
Inc., La Jolla, CA, USA) and R (R software, Development Core Team, Vienna, Austria; 
http://www.R-project.org, 2011) was conducted. The values of the relative thrombus density within 
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patients were compared using the paired t-test and represented as mean ± standard deviation or median 
and range where appropriate. Statistical significance was set as *: P<0.05, **: P<0.01, ***: P<0.001. 
 
 
 
 
Figure 1. Study design and patient selection. 
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Figure 2. The whole thrombus density measurement in mid-BA occluded 
patient with high-density thrombus (HBAS present). A: The borders of the 
whole thrombus drawn by polygonal selection tool in IMPAX workstation. B: 
The borders of the whole thrombus drawn by polygonal lasso tool in Image J. C: 
The borders in image B and image A showed overlap after the two images were 
merged. 
 
 
 
 
 
 
 
 
 
 
 
   
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Figure 3. Illustration of co-localization function of Agfa Technical Imaging 
System. A: White arrow indicates a transection of thrombus with low density in 
NECCT images. B: The cross line was used to identify an occlusion (an 
opacification gap) on CTA image (the corresponding slice to image A). C: An 
opacification gap at the top of BA in coronal view after multi-planar 
reconstruction (slice thickness 0.45mm). The cross-line emerged automatically 
when co-localization function was used. 
 
 
 
 
 
 
 
 
 
 
 
   
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Figure 4. Histograms of the density distribution of whole thrombi in three 
patients with high-density thrombi (A) and others with low-density thrombi (B). 
The intense blue curve indicates the fitted normal distribution curve. The orange 
line indicates the mean value of thrombus density deriving from three ROIs 
placed into the hyperdense vessel. The purple line indicates the mean value of 
thrombus density deriving from one ROI placement into the maximum dense 
part of the thrombi. The purple line is systematically shifted towards the right. 
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Figure 5. Illustration of three different methods of thrombus density 
measurement in one patient with top of basilar artery occlusion. The whole 
hyperdense vessel was encompassed within a ROI out of shape (Method 1, 
 ). Three (Method 2,  ) or One (Method 3,  ) circular ROIs were 
placed into the most hyperdense appearing part of the vessel. This was repeated 
in the normal-appearing contralateral or distal/proximal artery (HUcalibration). 
Hyperdensities with >100 HU were excluded. Absolute density (HUthrombus and 
HUcalibration) was determined by adding the density values of the ROIs divided by 
their numbers. The relative density was calculated by HUthrombus / HUcalibration. 
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Results 
Baseline characteristics of all 24 BAO patients were summarized in Table 1. The mean age of the 
patients was 69 years, and 2/3rd (n=16) were male. Proximal BA occlusion was observed in 29.2% 
(7/24), mid-BA occlusion was 50% (12/24), and top of the BA occlusion was 20.8% (5/24). HBAS 
was identified in 16 patients (66.7%, n=24). The median initial NIHSS was 18 (9–19 score, IQR), and 
the median time from onset to treatment (OTT) was 201 min (155–376 min, IQR). Successful 
recanalization was achieved in 15 patients (62.5%, n=24) and 6 patients (25%) resulted in the 
favorable outcome. The etiology of the stroke was cardiogenic (n=13), large atherosclerotic artery 
(n=7), and unknown (n=4), respectively, as assessed by the TOAST criteria. 
 
Normal distribution of thrombus density was observed in 9 patients (37.5%, n=24). An example of 
density distribution of the whole thrombus measurements isillustrated in Fig.4. The average value of 
the whole thrombus density (Method 1, in absolute Hounsfield values) was 53.8 ± 10.7 HU (mean) 
and 53.9 (46–61, IQR) (median). Both the average density measured by Method 2 (three ROIs 
placement) (58.7 ± 10.5 HU (mean) and 59 (52–66, IQR) (median)) or that measured by Method 3 
(one ROI placement) (63.1 ± 12.2 HU (mean) and 65 (54–72, IQR) (median)) are significantly higher 
than those derived from density distribution of the whole thrombus (Method 1) (P<0.0001, P<0.0001, 
respectively) (Table 2 and Fig. 6). 
 
The comparison of the relative density for all 24 BAO patients were represented in the order methods 
1 and 2, 3 (Fig. 4). The relative thrombus and normal vessel densities are summarized in Table 2. The 
relative densities were 1.64 ± 0.16, 1.58 ± 0.16, and 1.53 ± 0.15 respectively. After excluding the 
influence of the level of hematocrit on the measurement, the statistically significant differences were 
found among methods 1 and 2 and between methods1 and 3 with respect to relative density 
measurements (Fig. 7). 
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Table 1. Baseline characteristics of 24 BAO patients. 
 BAO patients (n=24) 
Mean age 69 ± 14 years 
Sex 8 females, 16 males 
Site of occlusion 
Proximal of BA: n=7 
Mid of BA: n=12 
Top of BA: n=5 
HBAS, n (%) 16 (66.7%) 
Median onset to treatment 201 (155–376, IQR) mins 
Median initial NIHSS 18 (9-19, IQR) 
Stroke etiology 
Cardioembolic: n=13 
Large artery: n=7 
Unknown: n=4 
Recanalization (TICI) 
0-1: n=5 
2a-3: n=19 
2b-3: n=15 
Outcome (mRS at 90 days) 
0-2: n=6 
0-3: n=10 
4-6: n=14 
IQR: Interquartile range. 
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Table 2. Mean and median values of the three methods (both absolute and 
relative thrombus density). 
  Density 
distribution 
(method 1) 
Three 
ROIs 
placement 
(method 2) 
One ROI 
placement 
(method 3) 
P value 
(method 2 
vs. method 
1) 
P value 
(method 
3vs. 
method 1) 
Absolute 
thrombus 
density 
(n=24) 
Mean ± SD,  
(HU) 
53.8 ± 10.7 58.7 ± 10.5 63.1 ± 12.2 P< 0.0001 P< 0.0001 
 
Median (HU) 53.9 59 65 
IQR 46-61 52-66 54-72 
Normal vessel 
(n=24) 
Mean ± SD,  
(HU) 
38.8 ± 3.1 41.5 ± 3.1 43.1 ± 3.8   
Relative 
thrombus 
density 
(n=24) 
Mean ± SD, 
(HU) 
1.53 ± 0.15 1.60 ± 0.16 1.65 ± 0.15 P = 0.0003 P = 0.0004 
Median (HU) 1.51 1.57 1.59 
IQR 1.41-1.60 1.47-1.71 1.53-1.77 
IQR: Interquartile range. 
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Figure 6. Boxplots demonstrated the differences of density of whole thrombus 
measurements (black boxplots) in comparison with density measured with three 
ROIs (orange boxplots) and one ROI (purple boxplot) placements both in 
high-density thrombi (A) and low-density thrombi (B). The horizontal line in the 
boxplot indicates median value, and the upper and lower lines of the box 
indicate Q1 and Q3 (IQR, respectively). NS: not significant. */**/***: 
significant at P<0.05/P<0.01/P<0.001, respectively. 
0
10
20
30
40
50
60
70
80
90
100
Different methods of thrombus density measurement
D
en
si
ty
 o
f t
he
 th
ro
m
bu
s 
(in
 H
U
)
Pat. 1 Pat. 2 Pat. 3 Pat. 4 Pat. 5 Pat. 6 Pat. 7 Pat. 8 
 
 
 
 
NS 
 
NS 
 
NS 
 
NS 
 
NS 
 
NS 
 
Thrombus with low density
0
10
20
30
40
50
60
70
80
90
100
Different methods of thrombus density measurement
D
en
si
ty
 o
f t
he
 th
ro
m
bu
s 
(in
 H
U
)
Pat. 1 Pat. 2 Pat. 3 Pat. 4 Pat. 5 Pat. 6 Pat. 7 Pat. 8 
 
 
NS 
 
NS 
 
 
 
NS 
 
NS 
 
NS 
 
NS 
 
Thrombus with high density A
B
Results                                                                                  48 
		
 
 
 
Fig. 7. Boxplots for absolute thrombus density, normal vessel density (A) and 
relative thrombus density (B) displaying mean, quartiles, and extreme values. *: 
significant at P<0.001, ns: not significant. 
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Discussion 
In this study, we compared three different methods for thrombus density measurement on thin-slice 
NECCT images. We found that ROI-based methods of thrombus density measurement yield largely 
different results in both absolute and relative density. Furthermore, in this small cohort, the density 
distribution of the whole thrombi showed a range of variation in the thrombus density rather than a 
single mean/median value, as calculated from three or one ROIs placements. Hence, the whole 
thrombus density measurements supplied more features of the thrombi than other two methods.  
 
Presently, limited studies are available on the thrombus density in BAO patients. To our knowledge, 
this is the first study comparing three different methods with respect to the measurement of thrombus 
density (both absolute and relative density) slice-by-slice on NECCT in BAO patients. Santos54 
reported that the average median of the thrombus density distribution was lower than those from two 
commonly used methods in patients with MCA occlusion, which is similar to our results found in 
BAO patients. However, our study revealed that the difference between three different methods could 
also be found in relative density. Moreover, the density distribution measurements in every slice 
provided supplementary information on thrombus density distribution than an average value in only 
one slice (Fig. 8). Since the RBC component was considered to correlate with thrombus attenuation45, 
the whole thrombus density measurement in every slice provided further insights on the thrombus 
composition. Previous studies measured the thrombus density slice-by-slice in patients with MCA 
occlusion20.However, a single mean/median value (in absolute density), rather than a range of 
variation, was used to represent the thrombus density. 
 
In this study, we found a significant density difference between the whole thrombus density 
measurements and median values of density measured by the other two methods (Table 2). This 
implies that the thrombus density calculated from the placements of multiple or one ROIs into the 
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maximum density part of the thrombi was overestimated as compared to the density distribution 
values; the results of the previous methods were rarely included in the analysis in the low-density parts 
of the thrombi. Consequently, this overestimation in the thrombus density might partially explain the 
correlation between thrombus density and successful recanalization and was demonstrated in some 
studies20-22, but not in others16, 23. 
 
The histological composition of thrombi has been demonstrated to be crucial for successful 
recanalization. A high content of red blood cells has been associated with successful mechanical 
thrombectomy and pharmacological thrombolysis43, 44. Thus, thrombus imaging has thus been the 
target of pretreatment imaging approaches. Compared to other two methods, the variation of thrombus 
distribution illustrated in the present study provided additional information about the heterogeneity of 
thrombus composition. Recently, Boeckh-Behrens55 reported that high percentages of WBCs, rather 
than RBCs, were related to organized thrombi of cardioembolic origin. The thrombi with HBAS (with 
high density) were RBC-prominent, and those without HBAS (with low density) were 
platelet-prominent. Thus, the whole density distribution measurement, which places the ROIs in both 
the high dense part and more importantly, the low dense part of the thrombi, might indicate the order 
of organization of the thrombi. Consequently, more mechanical features of the thrombus56 and the 
response of different compositions to various corresponding thrombectomy devices57, 58 could be 
determined47. 
 
In addition to different methods for the measurement of thrombus density, several other factors such 
as slice thickness were demonstrated to be crucial. In the literatures, a slice thickness between 2.5 and 
5 mm20-23 was used. The quantitative estimation of the whole thrombus density distribution on 
thin-slice NECCT images provided valuable details about thrombus composition. Furthermore, the 
differing and increasing efficacy of treatment modalities, such as intravenous thrombolysis and 
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mechanical thrombectomy, with new devices may also affect the observed density of successfully 
treated thrombi. Nevertheless, assessing the influence of these and additional factors59 was beyond the 
scope of this study, thereby necessitating further investigations. 
 
The present study has some limitations. First, due to the retrospective nature and small cohort, our 
results require substantiation in large population-based studies. Second, for some thrombi with blurred 
boundary or atherosclerotic changes in an obstructed BA, a part of blood or thickened endothelium of 
vessels around the thrombi was inevitably drawn into the density estimation by manual identification 
of the borderline of thrombi, thereby resulting in bias with respect to the assessment of thrombus 
density. Third, a standard method for thrombus density evaluation on NECCT images is lacking due to 
technical limitations. Some recent studies44, 45, 55 established the correlation between different 
dominated components in thrombi (for example, erythrocyte, WBC, platelet, and fibrin) and thrombus 
attenuation through histopathological analysis of the retrieved thrombus. However, due to the 
retrospective nature, the histological analysis for the retrieved clot could not be conducted. Moreover, 
although the density distribution of the whole thrombus instead of measurements using multiple or one 
ROIs placement provided sufficient information for estimation, the specific confidence interval of the 
distribution for the specific range of real thrombus density is yet to be determined. Further studies 
would develop a gold standard that might provide an accurate knowledge of the whole thrombus 
density, and then, the density range of radiographic estimation and different proportions of 
components in thrombi from histological analysis could be compared. Subsequently, the 
responsiveness to appropriate mechanical devices by the thrombus with different compositions would 
be investigated. As a result, efficient devices might lead to a reduced time taken for the intervention as 
well as increased incidence of favorable clinical outcome. 
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Figure 8. The point graph demonstrated density distribution of the whole 
thrombus derived from all consecutive slices (n=9) in which thrombus can be 
identified in a BAO patient. Each black dot represents one bin value within the 
thrombus by using Image J software (discussed in “Methods” section, Part I). 
All black dots in one column demonstrate the density distribution in one slice. 
The blue line that runs across the graph signifies the smoothed line of all mean 
value within the nine columns. For this BAO patient, the density distribution 
measurements provided different mean values of thrombus density from nine 
consecutive slices rather than one value from either slice. 
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Conclusion 
Different methods of the measurement of thrombus density on NECCT yield significantly varied 
results. Thus, the comparison among recently published studies is controversial. The whole thrombus 
density measured slice-by-slice should be taken into account the heterogeneity of the thrombus 
composition. While automated algorithms54 might be valuable, our results demonstrate that technical 
standards are needed. 
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General Discussion 
In this thesis, the prognostic value of thrombus characteristics including thrombus length and 
thrombus density on recanalization rate and clinical outcome in BAO patients were demonstrated (Part 
I). Furthermore, the comparison of three different methods of thrombus density measurement on 
thin-slice NECCT images was investigated (Part II). 
 
PART I. Prognostic value of thrombus characteristics on recanalization rate and clinical 
outcome in BAO patients treated with EVT. 
In this part, we evaluated the correlation between thrombus length and thrombus density with 
recanalization rate and clinical outcome. The results of Part 1 were two-fold. Our first finding is that 
successful recanalization could be achieved despite high clot burden in BAO patients treated with 
EVT. Similar to other studies16, 17, we did not find any relationship between thrombus length and the 
likelihood of recanalization. Clot length measurement might be useful for neurointerventionalists to 
plan the intervention and choose an appropriate mechanical device for thrombectomy, but the role of it 
in decision making is limited26. In contrast to other series16, the association between clot length and 
clinical outcome was not found in our study. This may be due to the rate of favorable clinical outcome 
in our series, which was a little lower (25.5%) than that published in previous studies9, 60-63 (around 
30~56%) and different methods used for thrombus length measurement. Rapid reperfusion could be 
accomplished by short OTT, effective mechanical devices, and experienced neurointerventionalist 
irrespective of clot burden. However, besides quick recanalization, patient characteristics, such as age, 
neurological deficit and collateral status should also be considered as predictors of clinical outcome. 
Therefore, the prognostic value of thrombus length on clinical outcome as an independent factor is 
limited and needs to be tested in larger trials. 
 
The second finding of our series showed that high density of thrombi is a strong predictor of favorable 
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clinical outcome, whereas the correlation between thrombus density and recanalization rate was not 
found in our cohort, which is in line with other series23. In contrast with previous study16, a significant 
association between high thrombus density and good outcome was found in our series. We 
hypothesized that low-density thrombi might be caused by atherosclerotic changes and partial volume 
effects may have blurred high attenuating thrombi but our secondary analysis didn’t substantiate this 
hypothesis. Nevertheless, due to our small cohort and lack of verification of thrombus composition, 
further studies could validate our finding in comparison of radiographic assessment and 
histopathological analysis of retrieved thrombi. 
 
PART II. Thrombus density measurements on non-enhanced cranial computed 
tomography: Comparison of three different methods. 
In this part, we compared three different methods for thrombus density measurement. We found the 
whole thrombus density measurements was statistically lower than single value measured by multiple 
or one ROIs placements, which indicated thrombus density might be overestimated by two methods 
that widely used in many studies. This overestimation of measured density might explain why a 
correlation between thrombus density and success recanalization found in some studies was not 
confirmed in others. On the other hand, different-ranged variation of density deriving from all 
corresponding slices of thrombi, as presented in Part II, revealed heterogeneity of thrombus 
composition. As a consequence, more mechanical features of the thrombus and the response of 
different thrombus composition to different corresponding thrombectomy devices should be evaluated. 
 
General Conclusion of this thesis 
It remains uncertain how thrombus characteristics assessment might alter clinical decision-making and 
optimize treatment strategies. This thesis provided evidence that successful recanalization could be 
achieved despite high clot burden in BAO patients treated with EVT, which indicate that there should 
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be no impact of thrombus length on treatment decision in the acute BAO patient. On the other hand, 
more insights should be given into thrombus density or thrombus composition, which could have 
clinical and technical implications. Automated whole thrombus algorithms could be helpful56. 
However, a gold standard method for thrombus density measurement is still needed. 
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